Drugs / GSK2189241A
last change May 2009 re-read 2 minutes ago

GSK2189241A

Developed for
streptococcal infection
Investigated by
GlaxoSmithKline

Trials 1 · a red edge is where a trial was stopped

2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00756067 Sep 2008 → May 2009 streptococcal infection GlaxoSmithKline Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as GSK2189241A ClinicalTrials.gov intervention name — accepted as the source's own label NCT00756067